- Home
- OSTX vs CIIT Comparison
OSTX vs CIIT Comparison
Compare OSTX & CIIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSTX
- CIIT
- Stock Information
- Founded
- OSTX 2018
- CIIT N/A
- Country
- OSTX United States
- CIIT Hong Kong
- Employees
- OSTX N/A
- CIIT N/A
- Industry
- OSTX
- CIIT
- Sector
- OSTX
- CIIT
- Exchange
- OSTX NYSE
- CIIT NYSE
- Market Cap
- OSTX 43.0M
- CIIT 36.0M
- IPO Year
- OSTX 2024
- CIIT N/A
- Fundamental
- Price
- OSTX $1.83
- CIIT $0.72
- Analyst Decision
- OSTX Strong Buy
- CIIT
- Analyst Count
- OSTX 3
- CIIT 0
- Target Price
- OSTX $18.00
- CIIT N/A
- AVG Volume (30 Days)
- OSTX 756.1K
- CIIT 277.9K
- Earning Date
- OSTX 08-14-2025
- CIIT 06-09-2025
- Dividend Yield
- OSTX N/A
- CIIT N/A
- EPS Growth
- OSTX N/A
- CIIT N/A
- EPS
- OSTX N/A
- CIIT N/A
- Revenue
- OSTX N/A
- CIIT $9,464,501.00
- Revenue This Year
- OSTX N/A
- CIIT N/A
- Revenue Next Year
- OSTX N/A
- CIIT N/A
- P/E Ratio
- OSTX N/A
- CIIT N/A
- Revenue Growth
- OSTX N/A
- CIIT 51.52
- 52 Week Low
- OSTX $1.12
- CIIT $0.60
- 52 Week High
- OSTX $7.00
- CIIT $5.38
- Technical
- Relative Strength Index (RSI)
- OSTX N/A
- CIIT N/A
- Support Level
- OSTX N/A
- CIIT N/A
- Resistance Level
- OSTX N/A
- CIIT N/A
- Average True Range (ATR)
- OSTX 0.00
- CIIT 0.00
- MACD
- OSTX 0.00
- CIIT 0.00
- Stochastic Oscillator
- OSTX 0.00
- CIIT 0.00
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.
About CIIT TIANCI INTERNATIONAL INC
Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.